NEWS & INSIGHTS

KnowHow: The FDB Blog

China Medicine

Can China Learn from USA Pharmacy Benefit Management?

Corporate Perspective, Government, Standards
Thursday, March 27, 2014
by Tom Bizzaro, RPh

In late February I was invited to speak at the Forum for Improving Drug Classification, Coding Standardization and Medical Insurance Database Management, a pharmacy forum sponsored by The China Health Insurance Research Association (CHIRA) and held in Beijing. It’s not surprising to learn that China faces many of the same challenges in pharmacy practice that we dealt with in the USA more than 25 years ago. Read More

Business Formula

The New York Average Acquisition Cost – AAC Done Right

Corporate Perspective, Drug Pricing
Thursday, January 30, 2014
by Patrick Lupinetti, JD

With FDB’s publication this week of a “draft” version of New York’s State’s Average Acquisition Cost (AAC) pricing, there’s a new alternative benchmark available, one distinctive enough to merit a closer look. Read More

Surgeon Using Computer

Will Meaningful Use of EHRs Prove Beneficial?


Monday, December 16, 2013
by Tom Bizzaro, RPh

In healthcare, where patients’ lives are on the line, facts and research matter. Read More

Welcome to Drug Knowledge

Brand

What if drug data was more than just data? > Visit the Media Centre for more videos.

Media Centre >